Objective:
To evaluate the impact of bone morphogenetic protein-2 (BMP-2) augmentation on radiographic bone consolidation and implant survivorship in revision total hip arthroplasty (THA) for severe acetabular defects, highlighting its potential significance in improving surgical outcomes.
Key Findings:
- 83% of hips showed more than 50% radiographic bone consolidation at final follow-up.
- No cases of graft resorption were observed.
- Implant survivorship was 90% at 6 years and 70% at 10 years when defined by all-cause reoperation.
- Survivorship was 90% at both time points when defined by acetabular loosening.
- Mean Oxford Hip Score among 13 hips was 35 at a mean of 84 months.
- 28% of hips experienced postoperative complications.
Interpretation:
BMP-2 augmentation appears to enhance bone consolidation and midterm implant survivorship in revision THA for severe acetabular defects, although further studies are necessary to confirm these findings.
Limitations:
- Retrospective study design, which may introduce bias.
- Small sample size limits generalizability.
- Lack of a control group makes it difficult to draw definitive conclusions.
- Absence of preoperative patient-reported outcomes limits understanding of baseline function.
- No cost-effectiveness analysis was performed.
- Single-surgeon experience at a tertiary referral center may not reflect broader practice.
Conclusion:
BMP-2 augmentation is associated with positive outcomes in revision THA for severe acetabular defects, warranting further investigation into its safety and efficacy to validate these promising results.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
